Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biofluid Biopsies

Robert Kinders's Biography



Robert Kinders, Sr. Principal Scientist and Head, Laboratory of Human Toxicology and Pharmacology, Frederick National Laboratory for Cancer Research

Robert Kinders is head of the Pharmacodynamics assay development (PADIS) laboratory at Frederick National Laboratory. The PADIS laboratory is charged with development and validation of assays to measure the effects, at the molecular level, of new, targeted anticancer agents in first-in-man clinical trials at the NCI Clinical Center. He received his Ph.D. in Biology at Kansas State University, and did post-doctoral studies at the University of Washington. His research has focused on cancer diagnostics and biomarkers. He has worked extensively in the U.S. Diagnostics Devices industry, including stints at Abbott Laboratories and C.R. Bard; and in pharmaceutical development at Abbott Laboratories and CuraGen.

Robert Kinders Image

Monitoring Drug Response Biomarkers in CTCs

Tuesday, 17 November 2015 at 11:30

Add to Calendar ▼2015-11-17 11:30:002015-11-17 12:30:00Europe/LondonMonitoring Drug Response Biomarkers in CTCsSELECTBIOenquiries@selectbiosciences.com

Ongoing Clinical Trials in the NCI network are employing a set of nuclear biomarkers to monitor drug activity on target. This presentation will review specific trials, biomarkers and CTC phenotypes analyzed on the ApoStream or CellSearch 5 channel platform.


Add to Calendar ▼2015-11-16 00:00:002015-11-17 00:00:00Europe/LondonBiofluid BiopsiesSELECTBIOenquiries@selectbiosciences.com